- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Triple Negative Breast Cancer
Total 11645 results
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...University of Milan; European Institute of Oncology; IFOM, The FIRC Institute...Active, not recruitingTriple-negative Breast CancerItaly
-
Guangdong Provincial People's HospitalCompletedTriple-Negative Breast CancerChina
-
Fudan UniversityActive, not recruiting
-
Tianjin Medical University Cancer Institute and...UnknownTriple-negative Breast CancerChina
-
Arbeitsgemeinschaft medikamentoese TumortherapieTakedaTerminatedTriple-Negative Breast CancerAustria
-
Jiangxi Provincial Cancer HospitalRecruitingTriple-Negative Breast CancerChina
-
BioNTech SESeventh Framework ProgrammeCompletedBreast Cancer (Triple Negative Breast Cancer (TNBC))Sweden, Germany
-
Sichuan Baili Pharmaceutical Co., Ltd.Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.Not yet recruiting
-
Fudan UniversityNot yet recruitingTriple-negative Breast Cancer
-
UNICANCERSOLTI Breast Cancer Research Group; Vall d'Hebron Institute of Oncology; MSD...Not yet recruitingTriple-negative Breast Cancer
-
Shanghai Jiao Tong University School of MedicineCSPC Ouyi Pharmaceutical Co., Ltd.; Innovent Biologics, Inc.Not yet recruiting
-
Fudan UniversityNot yet recruiting
-
Chipscreen Biosciences, Ltd.RecruitingTriple-negative Breast CancerChina
-
AHS Cancer Control AlbertaNot yet recruitingBreast Cancer Triple NegativeCanada
-
Fudan UniversityRecruitingTriple-negative Breast CancerChina
-
Fudan UniversityRecruitingTriple-negative Breast CancerChina
-
University of Kansas Medical CenterMerck Sharp & Dohme LLCActive, not recruitingTriple-negative Breast CancerUnited States
-
Hoffmann-La RocheCompletedTriple-Negative Breast CancerIsrael, United States, Australia, Korea, Republic of, Belgium, Argentina, Denmark, Finland, Italy, Portugal, Spain, Taiwan, Thailand, Japan, United Kingdom, Brazil, Canada, Colombia, Mexico, France, Costa Rica, Switzerland, Czechia, P... and more
-
SynCore Biotechnology Co., Ltd.Suspended
-
Hoffmann-La RocheCompletedTriple-Negative Breast CancerUnited States, Korea, Republic of, Spain, Brazil, Taiwan, Germany, Russian Federation, Australia
-
Washington University School of MedicineSusan G. Komen Breast Cancer FoundationWithdrawnTriple Negative Breast Cancer | Triple Negative Breast Neoplasms | Triple-Negative Breast Cancer
-
Taizhou Hanzhong biomedical co. LTDActive, not recruitingTriple-negative Breast CancerChina
-
Washington University School of MedicineSusan G. Komen Breast Cancer FoundationCompletedTriple Negative Breast Cancer | Triple Negative Breast Neoplasms | Triple-Negative Breast CancerUnited States
-
Roswell Park Cancer InstituteAIM ImmunoTech Inc.CompletedEstrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple -Negative Breast Cancer | Anatomic Stage IV Breast Cancer AJCCUnited States
-
Huihua XiongRecruiting
-
Wake Forest University Health SciencesMerck Sharp & Dohme LLC; G1 Therapeutics, Inc.RecruitingMetastatic Triple-Negative Breast CancerUnited States
-
Ministry of Health, Saudi ArabiaMaher M.aklNot yet recruitingTNBC - Triple-Negative Breast Cancer
-
Fudan UniversityRecruitingTNBC - Triple-Negative Breast CancerChina
-
First Affiliated Hospital of Shantou University...Guangdong ProCapZoom Biosciences Co., Ltd.Not yet recruitingAdvanced Triple Negative Breast CancerChina
-
Memorial Sloan Kettering Cancer CenterSynDevRx, Inc.RecruitingBreast Cancer | Metastatic Triple-Negative Breast CancerUnited States
-
The First Affiliated Hospital with Nanjing Medical...Not yet recruitingBreast Cancer | TNBC - Triple-Negative Breast Cancer
-
AstraZenecaActive, not recruitingMetastatic Triple Negative Breast CancerUnited States, Belgium, Italy, Spain, United Kingdom, Canada, Czechia, Poland, France, Korea, Republic of, Germany, Taiwan, Portugal, Netherlands, Ireland
-
Fudan UniversityActive, not recruitingTNBC - Triple-Negative Breast CancerChina
-
The Methodist Hospital Research InstituteCompletedMetastatic Triple Negative Breast CancerUnited States
-
Fudan UniversityCompletedAdvanced Triple-Negative Breast CancerChina
-
AHS Cancer Control AlbertaTom Baker Cancer CentreWithdrawnMetastatic Triple Negative Breast CancerCanada
-
Russian Academy of Medical SciencesCompletedEarly Triple Negative Breast CancerRussian Federation
-
University of WashingtonNational Cancer Institute (NCI)CompletedStage IV Breast Cancer | Triple-negative Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingBreast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | TNBC - Triple-Negative Breast CancerUnited States
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyCompletedMetastatic Breast Cancer | Metastatic Triple Negative Breast CancerJapan, Belgium, France, Netherlands
-
University of Maryland, BaltimoreSyndax PharmaceuticalsTerminatedStage I Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Triple-negative Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerUnited States
-
Joseph SparanoRecruitingBreast Neoplasms | Breast Diseases | Metastatic Triple Negative Breast CancerUnited States
-
Jules Bordet InstituteRecruitingTNBC - Triple-Negative Breast CancerBelgium
-
University Hospital TuebingenUniversity Hospital Freiburg; University Hospital UlmRecruitingTNBC - Triple-Negative Breast CancerGermany
-
Huihua XiongNot yet recruitingMetastatic Triple-negative Breast CancerChina
-
Aiping ShiRecruitingTriple Negative Breast Cancer (TNBC)China
-
Fujian Cancer HospitalNot yet recruitingAdvanced Triple Negative Breast CancerChina
-
PharmAbcineMerck Sharp & Dohme LLCRecruitingMetastatic Triple-Negative Breast CancerAustralia
-
Gilead SciencesParexel; IQVIA RDS (Shanghai) Co., Ltd.; Medidata Solutions; Q Squared Solutions...Active, not recruitingMetastatic Triple-negative Breast CancerChina
-
Yale UniversityIovance Biotherapeutics, Inc.CompletedMetastatic Triple Negative Breast CancerUnited States